| Original language | English (US) |
|---|---|
| Pages (from-to) | 102-131 |
| Number of pages | 30 |
| Journal | Journal of Lower Genital Tract Disease |
| Volume | 24 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1 2020 |
Keywords
- HPV testing
- cervical cytology
- guidelines
- management of abnormal cervical cancer screening tests
ASJC Scopus subject areas
- Obstetrics and Gynecology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Lower Genital Tract Disease, Vol. 24, No. 2, 01.04.2020, p. 102-131.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
AU - Perkins, Rebecca B.
AU - Guido, Richard S.
AU - Castle, Philip E.
AU - Chelmow, David
AU - Einstein, Mark H.
AU - Garcia, Francisco
AU - Huh, Warner K.
AU - Kim, Jane J.
AU - Moscicki, Anna Barbara
AU - Nayar, Ritu
AU - Saraiya, Mona
AU - Sawaya, George F.
AU - Wentzensen, Nicolas
AU - Schiffman, Mark
N1 - Funding Information: From the 1Boston University School of Medicine/Boston Medical Center, Boston, MA; 2University of Pittsburgh/Magee-Women's Hospital, Pittsburgh, PA; 3Albert Einstein College of Medicine, New York, NY; 4Virginia Commonwealth University School of Medicine, Richmond, VA; 5Rutgers, New Jersey Medical School, Newark, NJ; 6Pima County Health & Community Services, Tucson, AZ; 7UAB School of Medicine, Birmingham, AL; 8Harvard T.H. Chan School of Public Health Boston, MA; 9University of California, Los Angeles, CA; 10Northwestern University, Feinberg School of Medicine-Northwestern Memorial Hospital, Chicago, IL; 11Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA; 12University of California, San Francisco, San Francisco, CA; 13Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD; and 14Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, Bethesda, MD This article is open access, and reprints are available for download at asccp.org, jlgtd.com, or via pubmed. R.B.P. and R. S. G. contributed equally to the development of this manuscript and are co-first authors. The guidelines effort received support from the National Cancer Institute and ASCCP. Participating organizations supported travel for their participating representatives. All participating consensus organizations, including the primary funders, had equal and balanced roles in the consensus process including data analysis and interpretation, writing of manuscript, and decision to submit for publication. No industry funds were used in the development of these guidelines. The corresponding authors had final responsibility for the submission decision. The National Cancer Institute (including M.S. and N.W.) receives cervical screening results at reduced or no cost from commercial research partners
PY - 2020/4/1
Y1 - 2020/4/1
KW - HPV testing
KW - cervical cytology
KW - guidelines
KW - management of abnormal cervical cancer screening tests
UR - http://www.scopus.com/inward/record.url?scp=85083041609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083041609&partnerID=8YFLogxK
U2 - 10.1097/LGT.0000000000000525
DO - 10.1097/LGT.0000000000000525
M3 - Article
C2 - 32243307
AN - SCOPUS:85083041609
SN - 1089-2591
VL - 24
SP - 102
EP - 131
JO - Journal of Lower Genital Tract Disease
JF - Journal of Lower Genital Tract Disease
IS - 2
ER -